Market Research Reports

Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

106pages
Published Date: 2014-04-30
 

Description


Hyaluronic acid (HA) is a glycosaminoglycan that helps in transportation of nutrients through the body and facilitates water retention in body tissue. It is naturally found in body primarily in joints, eye cavity, immune system and others. Hyaluronic acid was observed to be an important component of articular cartilage where it is present in the form of a coat around each chondrocyte. The hyaluronic acid that is used as a medicine is extracted from rooster combs or made by bacteria in the laboratory. Hyaluronic acid contributes significantly to cell proliferation and migration, and sometimes also involved in the progression of some malignant tumors in the body. Hyaluronic acid found in the human body is mainly synthesized by three types of enzymes called hyaluronan synthases HAS1, HAS2 and HAS3.

The hyaluronic acid products market report studies the current scenario as well as the future market potential for hyaluronic acid products globally. The hyaluronic acid products market has been segmented on the basis of product types and types of applications. On the basis of products types, the market is segmented as single-injection, three-injection cycle and five-injection cycle. Further, the hyaluronic acid products applications market is segmented on the basis of types of various diseases and aging effects. The market for hyaluronic acid products has been extensively analyzed on the basis of factors such as demand of hyaluronic products in various applications, product prices on the basis of applications and brand analysis. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The hyaluronic acid products market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.

Geographically, the hyaluronic acid products market has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The hyaluronic acid products market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the hyaluronic acid products market report offers a qualitative analysis of the overall market considering the factors determining market dynamics such as drivers, restraints and opportunities. To understand the current and future market scenario of the hyaluronic acid products market Porter’s five force analysis and market attractiveness analysis covers the various aspects related to market environment. 

The hyaluronic acid products market report also provides a highlight of the competitive landscape of the market, wherein the heat map analysis of the important players in the market, along with the services offered by them has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The hyaluronic acid products market report concludes with the profiles of major players having presence in the market such as Allegran Inc., Anika Therapeutics, Inc., Merz Aesthetics, Inc., Sanofi (Genzyme), Seikagaku Corporation, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Inc., Alcon, Inc., Galderma S.A., Meiji Seika Pharma Co., Ltd., Salix Pharmaceuticals, Inc., Zimmer Holdings, Inc. and Smith & Nephew plc. Market players are profiled on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

The global hyaluronic acid products market is segmented as follows:
  • Hyaluronic Acid Products Market, by Products
    • Single-injection
    • Three-injection cycle
    • Five-injection cycle
  • Hyaluronic Acid Products Market, by Applications
    • Osteoarthritis
    • Ophthalmic
    • Dermal Fillers
    • Vesicoureteral Reflux (VUR)
  • Hyaluronic Acid Products Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Table of Contents


Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
      1.3.2 Assumptions and Stipulations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Hyaluronic Acid Products Market (2013 & 2019)
      2.1.1 Global Hyaluronic Acid Products Market, by Products, 2012 (USD Million)
2.2 Comparative Analysis: Global Hyaluronic Acid Products Market, By Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview
3.1 Introduction and Market Definition
3.2 Market Dynamics
      3.2.1 Drivers
      3.2.2 Restraints
      3.2.3 Market Opportunities
3.3 Porter’s Five Forces Analysis: Global Hyaluronic Acid Products Market
      3.3.1 Bargaining power of suppliers
      3.3.2 Bargaining power of buyers
      3.3.3 Threat of Substitutes
      3.3.4 Threat of New Entrants
      3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis
      3.4.1 Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
3.5 Global Market Share Analysis for the Hyaluronic Acid Products, by Key Players, 2012 (Value %)
      3.5.1 Global Market Share by Key Players, 2012 (Value %)

Chapter 4 Global Hyaluronic Acid Products Market, by Products
4.1 Overview
      4.1.1 Global Hyaluronic Acid Products Market Revenue, by Products, 2011 – 2019 (USD Million)
4.2 Single-Injection Cycle Products
      4.2.1 Global Single-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
4.3 Three-Injection Cycle Products
      4.3.1 Global Three-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
4.4 Five-Injection Cycle Products
      4.4.1 Global Five-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Hyaluronic Acid Products Market, by Applications
5.1 Overview
      5.1.1 Global Hyaluronic Acid Products Market Revenue, by Applications, 2011 – 2019 (USD Million)
5.2 Osteoarthritis
      5.2.1 Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2011 – 2019 (USD Million)
5.3 Ophthalmic
      5.3.1 Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2011 – 2019 (USD Million)
5.4 Dermal Fillers
      5.4.1 Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2011 – 2019 (USD Million)
5.5 Vesicoureteral Reflux (VUR)
      5.5.1 Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2011 – 2019 (USD Million)

Chapter 6 Global Hyaluronic Acid Products Market, by Geography
6.1 Overview
      6.1.1 Global Hyaluronic Acid Products Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
      6.2.1 North America Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
      6.3.1 Europe Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 RoW Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Recommendations
7.1 Market Strategy for Success
      7.1.1 Focus on improving technology in order to increase the accuracy and reduce side-effects
      7.1.2 Multinational companies established partnership with the local professional/organization to expand their business
7.2 Barriers to be considered
      7.2.1 High cost is a barrier for sufficient market expansion

Chapter 8 Company Profiles
8.1 Alcon, Inc.
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Allergan, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 Anika Therapeutics, Inc.
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 F. Hoffmann-La Roche Ltd.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Ferring Pharmaceuticals, Inc.
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Fidia Farmaceutici SpA
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product portfolio
      8.6.4 Business Strategies
      8.6.5 Recent developments
8.7 GALDERMA S.A.
      8.7.1 Company Profile
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Hyaltech Ltd.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 LifeCore Biomedical LLC,
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
8.10 Meiji Seika Pharma Co., Ltd.
      8.10.1 Company Profile
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments
8.11 Merz Aesthetics, Inc.
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Product Portfolio
      8.11.4 Business Strategies
      8.11.5 Recent Developments
8.12 Sanofi
      8.12.1 Company Overview
      8.12.2 Financial Overview
      8.12.3 Product Portfolio
      8.12.4 Business Strategies
      8.12.5 Recent Developments
8.13 Salix Pharmaceuticals, Inc.
      8.13.1 Company Overview
      8.13.2 Financial Overview
      8.13.3 Product Portfolio
      8.13.4 Business Strategies
      8.13.5 Recent Developments
8.14 Seikagaku Corporation
      8.14.1 Company Overview
      8.14.2 Financial Overview
      8.14.3 Product Portfolio
      8.14.4 Business Strategies
      8.14.5 Recent Developments
8.15 Shanghai Jingfeng Pharmaceutical Co., Ltd.
      8.15.1 Company Overview
      8.15.2 Financial Overview
      8.15.3 Product Portfolio
      8.15.4 Business Strategies
      8.15.5 Recent Developments
8.16 Smith & Nephew plc
      8.16.1 Company Overview
      8.16.2 Financial Overview
      8.16.3 Product Portfolio
      8.16.4 Business Strategies
      8.16.5 Recent Development
8.17 TRB CHEMEDICA INTERNATIONAL SA
      8.17.1 Company Overview
      8.17.2 Financial Overview
      8.17.3 Product Portfolio
      8.17.4 Business Strategies
      8.17.5 Recent Developments
8.18 Zimmer Holdings, Inc.
      8.18.1 Business Overview
      8.18.2 Financial Overview
      8.18.3 Product Portfolio
      8.18.4 Business Strategies
      8.18.5 Recent Developments

List of Figures

FIG. 1 Hyaluronic Acid Products: Market Segmentation
FIG. 2 Global Hyaluronic Acid Products Market, by Products, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Hyaluronic Acid Products Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Hyaluronic Acid Products Market
FIG. 5 Production Methods of Hyaluronic acid
FIG. 6 Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
FIG. 7 Market Share Analysis: Hyaluronic Acid Products Market, 2012 (Value %)
FIG. 8 Comparative Analysis: Types of Hyaluronic Acid Products
FIG. 9 Global Single-Injection Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Three-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Five-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2011 – 2019 (USD Million)
FIG. 13 Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2011 – 2019 (USD Million)
FIG. 14 Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2011 – 2019 (USD Million)
FIG. 15 Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2011 – 2019 (USD Million)
FIG. 16 North America Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Europe Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Asia-Pacific Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 RoW Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Alcon, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Allergan, Inc., Annual Sales Revenue: 2010 – 2012 (USD Million)
FIG. 22 Anika Therapeutics, Inc., Annual Revenue: 2010– 2012 (USD Million)
FIG. 23 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 Galderma S.A., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 25 Lifecore Biomedical LLC., Annual Revenue: 2010– 2012 (USD Million)
FIG. 26 Meiji Seika Pharma Co., Ltd., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Merz Aesthetics Inc., Annual revenue: 2010 – 2012 (USD Million)
FIG. 28 Sanofi, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Salix Pharmaceuticals, Inc., Annual Revenue: 2010 - 2012 (USD Million)
FIG. 30 Seikagaku Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Smith & Nephew PLC, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 32 Zimmer Holdings. Inc., Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Hyaluronic Acid Products Market (2013 & 2019)
TABLE 2 Global Hyaluronic Acid Products Market Revenue, by Products, 2011 –2019 (USD Million)
TABLE 3 Global Hyaluronic Acid Products Market Revenue, by Applications, 2011 –2019 (USD Million)
TABLE 4 Global Hyaluronic Acid Products Market Revenue, by Geography, 2011 –2019 (USD Million)

Enquiry Before Buying


Free Market Analysis


Hyaluronic acid (HA) is a unique non-sulfated glycosaminoglycan, distributed throughout the body in connective tissues, epithelial and neural tissues. Hyaluronic acid contributes significantly to cell proliferation and migration and is observed to be an integral component of the extracellular matrix. Hyaluronic acid has wide number of applications such as orthopedic surgery, rheumatology, ophthalmology, otolaryngology, dermatology and plastic surgery, wound healing and drug delivery. Hyaluronic acid products are segmented on the basis of treatment regimen into single-injection, three-injection cycle and five-injection cycle products. In addition, HA injectable can be utilized in a range of applications such as osteoarthritis, dermal fillers, ophthalmic surgery and vesicoureteral reflux (VUX).

The major factors driving this market are increasing geriatric population globally, high awareness about anti-aging procedures, patient’s preference for the treatment with minimum side-effects and rising demand for minimally invasive surgical procedures.

In products segment, five-injection cycle products is the largest marketsegment and single-injection market segment is growing with highest CAGR during forecast period from 2013 to 2019. Hyaluronic acid products market is observing a global shift in usage of five-injection cycle to single-injection cycle treatment as there has been a considerable change in preference of patients towards short duration treatment. This shift in preference is mainly related to convenience of patients as they try to avoid side-effects such as redness, inflammation and itching experienced after every treatment and five-injection cycle is a prolonged treatment compared to single-injection.

Dermal fillers is the largest market closely followed by osteoarthritis market and vesicoureteral reflux (VUR) applications market. VUR application market for hyaluronic acid products is growing at a highest CAGR during the forecast period from 2013 to 2019. The segment is mainly driven by aging population, high demand for minimally invasive surgical treatments and high awareness about beauty enhancements.

North America is the largest hyaluronic acid products market owing to high product demand, acceptance of premium priced products and high awareness about modern treatments. Europe is the second largest hyaluronic acid products market. It experienced an economic downturn that created turmoil in hyaluronic acid products marketas reimbursement policies turned out to be inconvenient and the premium priced products were accepted only in specific countries. Asia-Pacific and Rest of the World (RoW) were estimated to be the future hyaluronic acid products destinations as there is market driven by economic development, healthcare facility enhancements and high demand for minimally invasive surgeries.

Allergan, Inc., Anika Therapeutics, Inc. and Merz Aesthetics are major companies leading the hyaluronic acid products market. Major applications of hyaluronic acid products involves dermal filler and osteoarthritis treatment, hence, the major manufacturers have their product portfolio including hyaluronic acid injections applied in these two application areas.

global-hyaluronic-acid-products-market-by-segments-2012

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research